Showing 1 - 6 results of 6 for search 'Jacek Mackiewicz', query time: 0.02s Refine Results
  1. 1
    Programmed cell death 1 checkpoint inhibitors in the treatment of patients with advanced melanoma

    Programmed cell death 1 checkpoint inhibitors in the treatment of patients with advanced melanoma by Jacek Mackiewicz, Andrzej Mackiewicz

    Published 2017-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Elevated lactate dehydrogenase in adjuvant BRAF and MEK inhibitor therapy does not have diagnostic significance in detecting melanoma recurrence

    Elevated lactate dehydrogenase in adjuvant BRAF and MEK inhibitor therapy does not have diagnostic significance in detecting melanoma recurrence by Łukasz Galus, Daria Tusień-Małecka, Jacek Mackiewicz

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy

    Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy by Bożena Cybulska-Stopa, Iwona Ługowska, Rafał Wiśniowski, Małgorzata Domagała-Haduch, Marcin Rajczykowski, Karolina Piejko, Ilona Bar-Letkiewicz, Rafał Suwiński, Krzysztof Regulski, Jacek Mackiewicz

    Published 2020-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy

    Exploring correlations between gut mycobiome and lymphocytes in melanoma patients undergoing anti-PD-1 therapy by Natalia Szóstak, Michał Budnik, Katarzyna Tomela, Luiza Handschuh, Anna Samelak-Czajka, Bernadeta Pietrzak, Marcin Schmidt, Mariusz Kaczmarek, Łukasz Galus, Jacek Mackiewicz, Andrzej Mackiewicz, Piotr Kozlowski, Anna Philips

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    lncRNA <i>EGOT</i> Is the Marker of HPV Infection and a Prognostic Factor for HNSCC Patients

    lncRNA <i>EGOT</i> Is the Marker of HPV Infection and a Prognostic Factor for HNSCC Patients by Tomasz Kolenda, Piotr Białas, Kacper Guglas, Maciej Stasiak, Joanna Kozłowska-Masłoń, Karina Tylkowska, Anna Zapłata, Paulina Poter, Marlena Janiczek-Polewska, Patrycja Mantaj, Paulina Gieremek, Urszula Kazimierczak, Anna Przybyła, Katarzyna Regulska, Beata Stanisz, Ewa Leporowska, Andrzej Mackiewicz, Jacek Mackiewicz, Joanna Kazmierska, Zefiryn Cybulski, Anna Teresiak

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial

    Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716... by Dirk Schadendorf, Caroline Robert, Reinhard Dummer, Luis de la Cruz-Merino, Paolo A Ascierto, John M Kirkwood, Georgina V Long, Jacek Mackiewicz, Richard A Scolyer, Piotr Rutkowski, Jean-Jacques Grob, Jason John Luke, Michele Del Vecchio, Mizuho Kalabis, Adnan Khattak, Matteo S Carlino, Yujie Zhao, Alexander Eggermont, Vanna Chiarion Sileni, Clemens Krepler

    Published 2024-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: